Skip to main navigation Skip to search Skip to main content

SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

  • Constanze Schneider
  • , Thomas Oellerich
  • , Hanna-Mari Baldauf
  • , Sarah-Marie Schwarz
  • , Dominique Thomas
  • , Robert Flick
  • , Hanibal Bohnenberger
  • , Lars Kaderali
  • , Lena Stegmann
  • , Anjali Cremer
  • , Margarethe Martin
  • , Julian Lohmeyer
  • , Martin Michaelis
  • , Veit Hornung
  • , Christoph Schliemann
  • , Wolfgang E. Berdel
  • , Wolfgang Hartmann
  • , Eva Wardelmann
  • , Federico Comoglio
  • , Martin-Leo Hansmann
  • Alexander F. Yakunin, Gerd Geisslinger, Philipp Stroebel, Nerea Ferreiros, Hubert Serve, Oliver T. Keppler, Jindrich, Jr. Cinatl
  • University of Toronto, Canada

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)250-255
JournalNature Medicine
Volume23
Issue number2
Early online date19 Dec 2016
DOIs
Publication statusPublished - Feb 2017
Externally publishedYes

Cite this